New approach discovered for early detection of pre-eclampsia

April 24, 2018, Medical University of Vienna
Credit: shutterstock

In the last trimester of a pregnancy, a woman can develop high blood pressure and undesirable excretion of protein in the urine. If these symptoms of so-called pre-eclampsia are not treated, the condition could become life-threatening to both mother and baby. In collaboration with Harvard Medical School and St Anna Children's Cancer Research, a research team from MedUni Vienna led by molecular biologist Jürgen Pollheimer and clinical pharmacologist Bernd Jilma has now developed a new early detection technique. This involves measuring the blood concentration of the enzyme diamine oxidase, which is the enzyme jointly responsible for breaking down histamine in the body and which rises sharply in pregnant women.

If the body produces excessive amounts of the messenger substance histamine, this can lead to and even to anaphylactic shock. It has long been known in medical research that the diamine oxidase (DAO) can break down histamine. However, nobody has hitherto been able to directly prove and quantify this, only establish its activity. Apart from in the kidneys, large quantities of DAO are only found in the digestive tract of non-, as in men, where it breaks down the histamine absorbed from food. However, this activity increases 100 – 1000-fold in the blood of pregnant women and it was previously assumed that they were producing the enzyme themselves in order to prevent complications due to excessive histamine levels in the body.

The research group led by Jürgen Pollheimer from MedUni Vienna's Department of Obstetrics and Gynecology and Bernd Jilma from the Department of Clinical Pharmacology has now proven, for the very first time, that DAO is produced by the placenta, which is genetically associated with the baby. This production is down to a specific type of cells, extravillous trophoblasts. These cells are responsible, inter alia, for modifying the blood system in the uterus of pregnant women so that more blood is delivered to the placenta, thereby ensuring that the unborn baby receives sufficient nutrients.

The researchers' new study is based on the supposition that in pre-eclampsia, which has hitherto been very difficult to treat and affects approximately 5% of all pregnancies, it is precisely these cells that are damaged, so that less DAO is released into the mother's bloodstream. A new method was developed for quantifying the enzyme for the very first time. The researchers then analysed blood plasma samples from healthy pregnant women suffering from early-onset pre-eclampsia, provided by Brigham and Women's Hospital (part of Harvard Medical School) in Boston. Analyses showed that those patients who subsequently went on to suffer from pre-eclampsia already had significantly less DAO in their in the tenth week of pregnancy. It was therefore shown that the condition already manifests in early pregnancy before any symptoms occur.

It is intended to conduct follow-on studies into the causes of pre-eclampsia. However, apart from providing a new approach for the potential early detection of pre-eclampsia, the recent findings might also lead to new ways of treating -induced symptoms such as allergic reactions, if it is possible to produce diamine oxidase as a therapeutic infusion.

Explore further: Early onset of pregnancy complication may raise heart risks

More information: Philipp Velicky et al. Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia, Scientific Reports (2018). DOI: 10.1038/s41598-018-24652-0

Related Stories

Early onset of pregnancy complication may raise heart risks

September 15, 2017
(HealthDay)—Women who develop pre-eclampsia earlier in pregnancy may be at increased risk for heart problems soon after giving birth, a new study finds.

Study shows new biomarker could predict which pregnant women with type 1 diabetes could develop pre-eclampsia

September 14, 2017
Pregnant women with type 1 diabetes (T1D) are at a 4-times increased risk of pre-eclampsia compared to pregnant women without T1D. New research at this year's European Association for the Study of Diabetes (EASD) Annual Meeting ...

Serum biomarkers can predict women at risk of pre-eclampsia

July 22, 2015
Levels of biomarkers in the blood of pregnant women can be used to predict which women are at risk of pre-eclampsia, finds a study published today (22 July) in BJOG: An International Journal of Obstetrics and Gynaecology ...

Mothers with pre-eclampsia may encounter challenges later in life

August 25, 2017
A new study has found that a condition that threatens the lives of some pregnant women and the fetus may continue to put the mother at risk later in life.

Severe pre-eclampsia often leads to undetected high blood pressure after pregnancy

February 5, 2018
Lingering hypertension is common and may go unnoticed among women who have severe pre-eclampsia during pregnancy, according to new research in the American Heart Association's journal Hypertension.

Researchers help fight life-threatening pregnancy condition

June 24, 2013
Aston University researchers may have found a solution of a life-threatening pregnancy condition 'Pre-elcampsia'.

Recommended for you

Undiagnosed STIs can increase negative PMS symptoms

September 17, 2018
Women that have undiagnosed sexually transmitted infections may be at greater risk of experiencing negative premenstrual symptoms (PMS), according to new Oxford University research.

High dose folic acid does not prevent pre-eclampsia in high risk women

September 13, 2018
Taking high dose folic acid supplements in later pregnancy (beyond the first trimester) does not prevent pre-eclampsia in women at high risk for this condition, finds a randomised controlled trial published by The BMJ today.

Study finds air purifiers may benefit fetal growth

September 12, 2018
A new study led by SFU health sciences researchers Prabjit Barn and Ryan Allen reveals fetal growth may improve if pregnant women use portable air purifiers inside their homes.

Delayed childbearing is a growing source of multiple births, study shows

September 12, 2018
Starting in the 1980s, the number of multiple births—twins, triplets, quadruplets and quintuplets—steadily increased from about 20 sets per 1,000 live births to almost 35 sets per 1,000 live births in the 2010s.

Transforming pregnancy research with a smartphone app

September 5, 2018
For years, pregnant women have been underrepresented in biomedical research. Current treatments, interventions and guidelines do a poor job of taking into consideration the diverse characteristics of all pregnant women.

For women undergoing IVF, is fresh or frozen embryo transfer best?

August 21, 2018
The world's first baby born via in-vitro fertilization turned 40 years old this summer. Still, after four decades, IVF is a relatively new field with ongoing debate on how to get the best results for families who have placed ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.